Formidable Asset Management’s Myriad Genetics MYGN Stock Holding History

Formidable Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-150	Closed	-$5K	–	326
2016 Q1	$5K	Hold	150	–	–	﹤0.01%	405
2015 Q4	$6K	Hold	150	–	–	﹤0.01%	444
2015 Q3	$5K	Hold	150	–	–	﹤0.01%	499
2015 Q2	$5K	Hold	150	–	–	﹤0.01%	434
2015 Q1	$5K	Hold	150	–	–	﹤0.01%	429
2014 Q4	$5K	Hold	150	–	–	﹤0.01%	397
2014 Q3	$6K	Hold	150	–	–	﹤0.01%	378
2014 Q2	$6K	Hold	150	–	–	﹤0.01%	411
2014 Q1	$6K	Hold	150	–	–	﹤0.01%	368
2013 Q4	$5K	Hold	150	–	–	﹤0.01%	413
2013 Q3	$4K	Buy	+150	New	+$4.26K	﹤0.01%	379

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Formidable Asset Management's MYGN Position: Q2 2016 in Review

Formidable Asset Management sold out of Myriad Genetics (MYGN) in Q2 2016, closing a stake of 150 shares — an estimated $5K sold.

Formidable Asset Management first reported a position in MYGN in Q3 2013 and held it in 11 quarters. The position peaked at $6K in Q4 2015. 252 funds tracked by Wall St. Rank hold MYGN as of Q2 2016.

Formidable Asset Management reported no remaining Myriad Genetics position as of Q2 2016 after selling out during the quarter.
Formidable Asset Management sold 150 Myriad Genetics shares in Q2 2016, an estimated $5K.
Formidable Asset Management first reported a position in Myriad Genetics in Q3 2013 and held it in 11 quarters.
Formidable Asset Management's Myriad Genetics position peaked at $6K in Q4 2015.
252 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2016.

Based on Formidable Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.